Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01106534
Show Display Options
Download search resultsDownload the search results for:
NCT01106534 (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed
Has Results
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Conditions: Chronic Total Occlusion of Coronary Artery;   Vascular Disease;   Myocardial Ischemia;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Artery Disease;   Coronary Restenosis
Interventions: Drug: placebo + aspirin;   Drug: clopidogrel + aspirin OR prasugrel + aspirin;   Device: XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS)

Indicates status has not been verified in more than two years